Andreas Strüngmann: Difference between revisions
Content deleted Content added
m the work's name is "The New York Times" using AWB |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer.<ref>Timmons, Heather & Wright, Tom. [https://www.nytimes.com/2005/02/22/business/worldbusiness/22drug.html?pagewanted=print&position=&_r=0 "Novartis to Buy Two Makers of Generics"]. ''[[The New York Times]]'', 22 February 2005. Retrieved on 27 May 2013.</ref> In February 2005, he and his brother [[Thomas Strüngmann|Thomas]] sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion,<ref>''[[Forbes]]''. [https://www.forbes.com/profile/andreas-strungmann/ "Andreas Strungmann - Forbes"]. March 2013. Retrieved on 27 May 2013.</ref> making [[Sandoz]] the largest generic-drug company in the world. |
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer.<ref>Timmons, Heather & Wright, Tom. [https://www.nytimes.com/2005/02/22/business/worldbusiness/22drug.html?pagewanted=print&position=&_r=0 "Novartis to Buy Two Makers of Generics"]. ''[[The New York Times]]'', 22 February 2005. Retrieved on 27 May 2013.</ref> In February 2005, he and his brother [[Thomas Strüngmann|Thomas]] sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion,<ref>''[[Forbes]]''. [https://www.forbes.com/profile/andreas-strungmann/ "Andreas Strungmann - Forbes"]. March 2013. Retrieved on 27 May 2013.</ref> making [[Sandoz]] the largest generic-drug company in the world. |
||
He currently has residences in [[Tegernsee]], Germany, Europe and |
He currently has residences in [[Tegernsee]], Germany, Europe and South-Africa and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis. |
||
==See also== |
==See also== |
||
Revision as of 03:10, 7 October 2018
Andreas Strüngmann (born 1950) was born in Germany and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer.[1] In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion,[2] making Sandoz the largest generic-drug company in the world.
He currently has residences in Tegernsee, Germany, Europe and South-Africa and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.
See also
References
- ^ Timmons, Heather & Wright, Tom. "Novartis to Buy Two Makers of Generics". The New York Times, 22 February 2005. Retrieved on 27 May 2013.
- ^ Forbes. "Andreas Strungmann - Forbes". March 2013. Retrieved on 27 May 2013.
External links
| International | |
|---|---|
| National | |
 | This German business-related biographical article is a stub. You can help Wikipedia by expanding it. |